Información del producto
Nombre:
trans-Ned 19
Sinónimos:
- 1H-Pyrido[3,4-b]indole-3-carboxylic acid, 1-[3-[[4-(2-fluorophenyl)-1-piperazinyl]methyl]-4-methoxyphenyl]-2,3,4,9-tetrahydro-, (1R,3S)-
- (1R,3S)-1-[3-[[4-(2-Fluorophenyl)-1-piperazinyl]methyl]-4-methoxyphenyl]-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylic acid
Descripción:
Trans-Ned 19 is a dinucleotide phosphate that has been shown to inhibit intracellular Ca2+ levels. It has been studied as a potential anticancer agent in animal models and is also being investigated for use in the treatment of autoimmune diseases, such as rheumatoid arthritis and multiple sclerosis. Trans-Ned 19 is an acidic compound, which may be due to its ability to modulate mitochondrial membrane potential. This agent can inhibit glutamate-induced cytosolic Ca2+ release and autophagy in cardiomyocytes, which may contribute to its anticancer activity.
Aviso:
Nuestros productos están destinados únicamente para uso en laboratorio. Para cualquier otro uso, por favor contáctenos.
Marca:
Biosynth
Almacenamiento de larga duración:
Notas:
Propiedades químicas
Peso molecular:
514.59 g/mol
Fórmula:
C30H31FN4O3
Pureza:
Min. 95%
MDL:
Punto de fusión:
Punto de ebullición:
Punto de inflamabilidad:
Densidad:
Concentración:
EINECS:
Merck:
Código HS:
